Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe diseaseMarc Nicolino, Priya S. Kishnani, Barry J. Byrne et al.|Genetics in Medicine|2009Cited by 292
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 studyDo‐Youn Oh, Juan W. Valle, Shukui Qin et al.|The Lancet. Gastroenterology & hepatology|2024Cited by 245